Gomes, Antoniel A. S.
Santos, Natália C. M.
Rosa, Leonardo R.
Borges, Rafael J.
Fontes, Marcos R. M.
Hamil, Katherine G.
O’Rand, Michael G.
Silva, Erick J. R.
Funding for this research was provided by:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88882.183574/2017-01)
Fundação de Amparo à Pesquisa do Estado de São Paulo (2023/04496-2, 2015/08227-0)
Conselho Nacional de Desenvolvimento Científico e Tecnológico (303616/2022-9)
Article History
Received: 5 July 2023
Accepted: 25 August 2023
First Online: 1 September 2023
Competing interests
: Michael G. O'Rand has stock ownership in Eppin Pharma Inc. Dr. O'Rand receives no salary from Eppin Pharma. He is retired from the University but retains his association with UNC and the Department of Cell Biology & Physiology. Katherine G. Hamil has stock ownership in Eppin Pharma Inc. She is a full-time employee of Eppin Pharma. This does not alter our adherence to policies on sharing data and materials. There are no restrictions on sharing our data. The other authors declare no competing interests.